Mark Flather
Vice President of Investor Relations
Head of Investor Relations
Earnings-call appearances
-
Vistagen Therapeutics, Inc. Q1 FY2024 Earnings Call2023-08-10
Vistagen Therapeutics, Inc. (VTGN)
-
Vistagen Therapeutics, Inc. Q3 FY2023 Earnings Call2023-02-07
Vistagen Therapeutics, Inc. (VTGN)
-
Vistagen Therapeutics, Inc. Q1 FY2023 Earnings Call2022-08-11
Vistagen Therapeutics, Inc. (VTGN)
-
Vistagen Therapeutics, Inc. Q3 FY2022 Earnings Call2022-02-10
Vistagen Therapeutics, Inc. (VTGN)